Serial QuantiFERON-TB Gold In-Tube testing for psoriatic patients receiving antitumor necrosis factor-alpha therapy
Background/Objective: Tumor necrosis factor-α (TNF-α) antagonists have become increasingly popular in the treatment of psoriasis. However, the increased risk of latent tuberculosis infection (LTBI) reactivation has also become an important issue in clinical practice. The aim of this study was to eva...
Main Authors: | Chun-Yu Cheng, Rosaline Chung-Yee Hui, Sindy Hu, Meng-Heng Hsieh, Yu-Huei Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-09-01
|
Series: | Dermatologica Sinica |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S102781171400086X |
Similar Items
-
Frequency and Factors of Indeterminate QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold PLUS Test Results in Rheumatic Diseases
by: Sung Soo Ahn, et al.
Published: (2021-09-01) -
QuantiFERON® TB GOLD’ s applications in the tuberculosis disease
by: Maria Saladino, et al.
Published: (2014-06-01) -
Clinical utility of QuantiFERON TB Gold Test in the diagnosis of latent tuberculosis infections
by: Salvatore Nisticò, et al.
Published: (2010-03-01) -
QuantiFERON® TB Gold IT in the diagnosis of active pulmonary TB
by: Clara Fabris, et al.
Published: (2010-03-01) -
QuantiFERON-TB reversion in children and adolescents with tuberculosis
by: Paula Rodríguez-Molino, et al.
Published: (2024-03-01)